BET inhibitor nanotherapy halts kidney damage and reduces chronic kidney disease progression after ischemia-reperfusion injury.
Saiz ML, Lozano-Chamizo L, Florez AB, Marciello M, Diaz-Bulnes P, Corte-Iglesias V, Bernet CR, Rodrigues-Diez RR, Martin-Martin C, Rodriguez-Santamaria M, Fernandez-Vega I, Rodriguez RM, Diaz-Corte C, Suarez-Alvarez B, Filice M, Lopez-Larrea C.
Saiz ML, et al. Among authors: martin martin c.
Biomed Pharmacother. 2024 May;174:116492. doi: 10.1016/j.biopha.2024.116492. Epub 2024 Mar 26.
Biomed Pharmacother. 2024.
PMID: 38537579
Free article.